Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to $142.1 million.

  • Cytokinetics' Total Current Liabilities rose 29.44% to $142.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.1 million, marking a year-over-year increase of 29.44%. This contributed to the annual value of $179.7 million for FY2024, which is 74.99% up from last year.
  • Cytokinetics' Total Current Liabilities amounted to $142.1 million in Q3 2025, which was up 8.45% from $131.1 million recorded in Q2 2025.
  • In the past 5 years, Cytokinetics' Total Current Liabilities registered a high of $179.7 million during Q4 2024, and its lowest value of $35.9 million during Q1 2021.
  • For the 3-year period, Cytokinetics' Total Current Liabilities averaged around $112.3 million, with its median value being $102.8 million (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first spiked by 193.29% in 2021, then declined by 5.41% in 2022.
  • Cytokinetics' Total Current Liabilities (Quarterly) stood at $71.9 million in 2021, then grew by 17.75% to $84.6 million in 2022, then grew by 21.34% to $102.7 million in 2023, then skyrocketed by 74.99% to $179.7 million in 2024, then grew by 29.44% to $142.1 million in 2025.
  • Its Total Current Liabilities was $142.1 million in Q3 2025, compared to $131.1 million in Q2 2025 and $159.7 million in Q1 2025.